ArticleScientific reports2025
Hepatitis B virus infection and associated risk factors among mothers attending public health facilities in Bahir Dar, Northwest Ethiopia.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Hepatitis B and D burden in Uzbekistan: comprehensive analysis of seroprevalence and risk correlates from a countrywide study.Infectious diseases of poverty · 2026Article
- Prevalence of chronic hepatitis B virus infection and associated factors among pregnant women attending antenatal care at Felege Hiwot Comprehensive Specialized Hospital Ethiopia.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Globally, the burden of hepatitis B virus (HBV) infection is a serious health problem for women that could be transmitted to their newborn infants. Screening and treating at an early stage help prevent the spread of this infection and its complications. Therefore, the study aimed to assess the seroprevalence and associated risk factors of HBV infection among mothers attending public health facilities in Bahir Dar, Northwest Ethiopia. A cross-sectional study was conducted in a total of 325 mothers attending Bahir Dar city public health facilities from December 2023 to June 2024. Data on sociodemographic characteristics and possible risk factors were collected using a structured questionnaire, and serum samples were screened for hepatitis B surface antigen (HBsAg) using sandwich enzyme-linked immunosorbent assays (ELISA). Data were entered and analyzed using SPSS version 23 software. Logistic regression was used to check the association between variables with an odds ratio (OR) at 95% confidence intervals (CI). P-value ≤ 0.05 was considered statistically significant. The overall seroprevalence of HBV infection was 3.4% (95% CI; 1.0-5.0). The history of sexually transmitted diseases (STDs) (AOR = 7.60; 95% CI: 1.84-31.34, p = 0.005), history of contact with chronic hepatitis B virus-infected (CHB) family members (AOR = 20.86; 95% CI: 2.48-175.03, p = 0.005), and female circumcision (AOR = 13.76; 95% CI: 1.63-116.80, p = 0.016) were significantly associated risk factors with HBV infection. Generally, an intermediate seroprevalence of HBV infection was reported in this study. This showed that HBV infection is still a critical public health concern among mothers in the study area. History of contact with CHB family members, history of STDs, and female circumcision were significantly associated risk factors with HBV infection. These findings call for enhanced public health strategies to effectively reduce HBV infection in mothers.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.